Repurposing of Fluvastatin as an Anticancer Agent against Breast Cancer Stem Cells via Encapsulation in a Hyaluronan-Conjugated Liposome
Fluvastatin (FLUVA), which is a common anti-hypercholesterolemia drug, exhibits potential anticancer activity as it suppresses the proliferation, angiogenesis, and metastasis of breast cancer cells via inhibiting 3-hydroxy-methyl glutaryl-coenzyme A (HMG-CoA) reductase. In this study, hyaluronan-con...
Saved in:
Main Authors: | Ji Su Yu (Author), Dae Hwan Shin (Author), Jin-Seok Kim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells
by: Jeong Hyun Shin, et al.
Published: (2020) -
Repurposing Tranexamic Acid as an Anticancer Agent
by: Mary E. Law, et al.
Published: (2022) -
Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems
by: Noemi Bognanni, et al.
Published: (2023) -
Dual Role of Vitamin C-Encapsulated Liposomal Berberine in Effective Colon Anticancer Immunotherapy
by: Martyna Mianowska, et al.
Published: (2023) -
Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
by: Muhammad Ali, et al.
Published: (2024)